Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed

Haemophilia. 2019 Jul;25(4):e291-e293. doi: 10.1111/hae.13765. Epub 2019 May 2.

Authors

Vuokko Nummi^{1

2}, Elina Lehtinen², Anne Mäkipernaa², Timea Szanto³, Riitta Lassila^{1

2}

Affiliations

¹ Faculty of Medicine, University of Helsinki, Helsinki, Finland.
² Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
³ Coagulation Disorder Unit, Department of Clinical Chemistry, HUSLAB Laboratory Services, Helsinki University Hospital, Helsinki, Finland.

PMID: 31050121
DOI: 10.1111/hae.13765

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Female
Gastrointestinal Hemorrhage / complications*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Isoantibodies / administration & dosage
Isoantibodies / therapeutic use*
Middle Aged
Treatment Outcome
von Willebrand Disease, Type 3 / complications*
von Willebrand Disease, Type 3 / drug therapy*
von Willebrand Disease, Type 3 / immunology

Substances

Immunoglobulins, Intravenous
Isoantibodies